Opthea Limited
CKDXF
$0.44
-$0.13-22.81%
Weiss Ratings | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.32 | |||
Price History | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | -22.81% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 51.72% | |||
2-Year Total Return | -46.34% | |||
3-Year Total Return | -46.34% | |||
5-Year Total Return | -81.89% | |||
52-Week High % Change | -22.81% | |||
52-Week Low % Change | 0.00% | |||
Price | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.57 | |||
52-Week Low Price | $0.44 | |||
52-Week Low Price (Date) | Nov 14, 2024 | |||
52-Week High Price (Date) | Oct 16, 2024 | |||
Valuation | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 470.04M | |||
Enterprise Value | 562.66M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.29 | |||
Earnings Per Share Growth | -11.76% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 4,400.00 | |||
Price/Book (Q) | -3.21 | |||
Enterprise Value/Revenue (TTM) | 2,810.50 | |||
Price | $0.44 | |||
Enterprise Value/EBITDA (TTM) | -3.20 | |||
Enterprise Value/EBIT | -3.20 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 1.22B | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 61 3 9826 0399 | |||
Address | 650 Chapel Street South Yarra, VIC 3141 | |||
Website | opthea.com | |||
Country | Australia | |||
Year Founded | 1984 | |||
Profitability | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -87,833.17% | |||
Profit Margin | -122,710.25% | |||
Management Effectiveness | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -73.34% | |||
Return on Equity | -- | |||
Income Statement | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 87.80K | |||
Total Revenue (TTM) | 208.60K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 357.40K | |||
EBITDA (TTM) | -183.20M | |||
EBIT (TTM) | -183.22M | |||
Net Income (TTM) | -255.97M | |||
Net Income Avl. to Common (TTM) | -255.97M | |||
Total Revenue Growth (Q YOY) | -26.24% | |||
Earnings Growth (Q YOY) | -29.73% | |||
EPS Diluted (TTM) | -0.29 | |||
EPS Diluted Growth (Q YOY) | 37.02% | |||
Balance Sheet | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 131.92M | |||
Cash Per Share (Q) | $0.11 | |||
Total Current Assets (Q) | 144.12M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -168.71M | |||
Current Ratio (Q) | 1.571 | |||
Book Value Per Share (Q) | -$0.14 | |||
Total Assets (Q) | 145.77M | |||
Total Current Liabilities (Q) | 91.75M | |||
Total Debt (Q) | 222.75M | |||
Total Liabilities (Q) | 314.48M | |||
Total Common Equity (Q) | -168.71M | |||
Cash Flow | CKDXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -33.20K | |||
Cash from Financing (TTM) | 243.73M | |||
Net Change in Cash (TTM) | 83.28M | |||
Levered Free Cash Flow (TTM) | -81.05M | |||
Cash from Operations (TTM) | -161.02M | |||